Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.890

+2.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Haythorn who wrote (36)	5/5/1997 7:46:00 PM
From: Shlepper	of 233

Thanks Mark... Your numbers sound pretty reasonable, although they'll be getting about 25 million from Schering before they even sell the drugs - upon milestones being met. At least Magainin has some fairly good, knowledgable people now to get the process moving as quickly as possible. They've gone the route of bringing in experienced experts in the fields. Guilford hired FDA people so that they'd know how to get through the process and that paid off handsomely. In any event 2 years is about my timeline, but if things seem to be moving along smoothly, it'll be worth the wait. I think that Magainin has enough cash on hand for the 2 years. I hope that they don't have to dilute much further to keep things rolling. I'm still excited about their newer drugs, but am disappointed that the teaming arrangement with P&G seems to have been dropped - weren't they looking to use Magainin against gingivitis? Anyway, let's all keep in touch and watch the progess... Enjoy! Shep

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next